Addex Therapeutics ADXN
NASDAQ ADXN
$2.96 +0.22 (+8.03%)
At close: Nov 10, 2026 · 4:00 PM EST

Addex Therapeutics (ADXN) Other Non-Current Assets (2020 - 2025)

Updated

Addex Therapeutics (ADXN) posted Other Non-Current Assets of $72,563 for Q2 2025.

Analysis

Addex Therapeutics (ADXN) Other Non-Current Assets (2020 - 2025) Analysis & Trends

At the end of FY2024, Addex Therapeutics' Other Non-Current Assets came in at $9,056.

  • Annual Other Non-Current Assets shows a four-year compound annual growth rate of -52.6% (FY2020 to FY2024).
  • In prior years, Addex Therapeutics' Other Non-Current Assets was $180,125 in FY2020.
  • The Q2 2025 figure stands as the highest quarterly Other Non-Current Assets since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 15.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.42 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 700.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.90 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.02 Bn
10 Addex Therapeutics 3.65 Mn -3.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 75,257.13
Dec 31, 2024 8,820.47
Mar 31, 2024 876,602.22
Dec 31, 2020 184,712.68
API Access

Addex Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ADXN&period=max&api_key=YOUR_API_KEY